Shanghai Haohai Biological Technology Co., Ltd. (SHA:688366)
53.00
-0.10 (-0.19%)
May 23, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Medical Aesthetics and Wound Care | 1.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Aesthetics and Wound Care Growth | 41.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ophthalmic | 928.21M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ophthalmic Growth | 20.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Orthopedic | 476.09M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Orthopedic Growth | 22.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anti-Adhesion and Hemostatic | 141.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anti-Adhesion and Hemostatic Growth | -19.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 46.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -0.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 2.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 27.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Countries | 196.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Countries Growth | 23.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 136.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | -3.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 120.28M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 15.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|